Brief: Phio Pharmaceuticals Has Approved A Reverse Stock Split Of Its Shares Of Common Stock At A Ratio Of 1-For-9
July 2 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS CORP - HAS APPROVED A REVERSE STOCK
SPLIT
OF ITS SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-9
* PHIO PHARMACEUTICALS CORP - REVERSE STOCK SPLIT WILL
BECOME
EFFECTIVE ON JULY 5
* PHIO PHARMACEUTICALS - REVERSE STOCK SPLIT IS BEING
IMPLEMENTED
TO COMPLY WITH MINIMUM BID PRICE REQUIREMENT FOR CONTINUED
LISTING ON NASDAQ
Source text for Eikon: ID:n0001683168-24-004619
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing